These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35789068)

  • 1. Real-world KINDLE-Latin America subset data on treatment patterns and clinical outcomes in patients with stage III non-small-cell lung cancer.
    Martin CM; Puello-Guerrero A; Mas-Lopez LA; Campos-Gómez S; Orlando-Orlandi FJ; Tejado Gallegos LF; Huggenberger R
    Cancer Med; 2023 Jan; 12(2):1247-1259. PubMed ID: 35789068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-World Treatment Patterns and Clinical Outcomes in Patients With Stage III NSCLC: Results of KINDLE, a Multicountry Observational Study.
    Jazieh AR; Onal HC; Tan DSW; Soo RA; Prabhash K; Kumar A; Huggenberger R; Robb S; Cho BC
    J Thorac Oncol; 2021 Oct; 16(10):1733-1744. PubMed ID: 34051381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-World Treatment Patterns and Clinical Outcomes in Patients With Stage III Non-Small-Cell Lung Cancer: Results of KINDLE-Vietnam Cohort.
    Van Dao T; Diep TB; Le Phuong T; Huggenberger R; Kumar A
    Front Oncol; 2022; 12():842296. PubMed ID: 35677172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-world treatment patterns and clinical outcomes in patients with stage III non-small cell lung cancer: results of KINDLE-Egypt cohort.
    Aboelhassan R; Sobeih ME; El-Din MA; Ghali RR; El-Din IS; Khorshid O; Mokhtar M; Rabea AM; Belal A; Azim HA; Abdullah M; Elnahas T; Tawfik H; Abdelwahab S; Elsaid AA; Hashem T; Mancy M; Farag H
    Ther Adv Med Oncol; 2023; 15():17588359231212182. PubMed ID: 38028146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-world clinical practice and outcomes in treating stage III non-small cell lung cancer: KINDLE-Asia subset.
    Prabhash K; Tan DSW; Soo RA; Sitthideatphaiboon P; Chen YM; Voon PJ; Syahruddin E; Chu S; Huggenberger R; Cho BC
    Front Oncol; 2023; 13():1117348. PubMed ID: 37051534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-world Treatment Patterns and Outcomes in Stage III Non-small Cell Lung Cancer: Middle East and Africa - KINDLE Study.
    Jazieh AR; Sağlam EK; Önal HC; Abdelkader Y; Gaafar R; Dawoud E; Nassar M; Alshorbagy D; El Ashry H; Elsayed M
    Clin Lung Cancer; 2022 Jun; 23(4):364-373. PubMed ID: 35277345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-world treatment patterns and clinical outcomes in patients with stage III NSCLC in Korea: The KINDLE study.
    Lee J; Ahn HK; Kim SW; Han JY; Lee SS; Park HS; Lee HW; Kim JH; Cho E; Huggenberger R; Cho BC
    Cancer Med; 2024 Apr; 13(7):e7174. PubMed ID: 38622869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should patients with stage IB non-small cell lung cancer receive adjuvant chemotherapy? A comparison of survival between the 8th and 7th editions of the AJCC TNM staging system for stage IB patients.
    Wang J; Wu N; Lv C; Yan S; Yang Y
    J Cancer Res Clin Oncol; 2019 Feb; 145(2):463-469. PubMed ID: 30474757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival results and prognostic factors in T4 N0-3 non-small cell lung cancer patients according to the AJCC 7th edition staging system.
    Arslan D; Bozcuk H; Gunduz S; Tural D; Tattli AM; Uysal M; Goksu SS; Bassorgun Cİ; Koral L; Coskun HS; Ozdogan M; Savas B
    Asian Pac J Cancer Prev; 2014; 15(6):2465-72. PubMed ID: 24761848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-year survival of resectable stage IIIA non-small cell lung cancer in Brazil.
    de Barros MLGP; Silva VG; Moreira FR; Perez SV; Younes RN; Abrão FC
    J Surg Oncol; 2023 Dec; 128(7):1195-1204. PubMed ID: 37448240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemotherapy with docetaxel-cisplatin in patients with stage III N2 non-small-cell lung cancer.
    Liao WY; Chen JH; Wu M; Shih JY; Chen KY; Ho CC; Yang JC; Yu CJ
    Clin Lung Cancer; 2013 Jul; 14(4):418-24. PubMed ID: 23291258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-world study of disease-free survival & patient characteristics associated with disease-free survival in early-stage non-small cell lung cancer: A retrospective observational study.
    Shah A; Apple J; Belli AJ; Barcellos A; Hansen E; Fernandes LL; Zettler CM; Wang CK
    Cancer Treat Res Commun; 2023; 36():100742. PubMed ID: 37478531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-world treatment patterns and survival outcomes for advanced non-small cell lung cancer in the pre-immunotherapy era in Portugal: a retrospective analysis from the I-O Optimise initiative.
    Soares M; Antunes L; Redondo P; Borges M; Hermans R; Patel D; Grimson F; Munro R; Chaib C; Lacoin L; Daumont M; Penrod JR; O'Donnell JC; Bento MJ; Rocha Gonçalves F
    BMC Pulm Med; 2020 Sep; 20(1):240. PubMed ID: 32912174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment outcome of locally advanced stage IIIA/B lung cancer].
    Cicenas S; Zaliene A; Atkocius V
    Medicina (Kaunas); 2009; 45(6):452-9. PubMed ID: 19605965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential Efficacy of Anti-VEGF Antibodies Based on Sex and Race in a Diverse Cohort of Advanced Nonsquamous Non-Small Cell Lung Cancer.
    Sukrithan V; Barbaro A; Chergui A; Ko B; Lin J; Cheng H; Goel S
    Am J Clin Oncol; 2020 Jan; 43(1):64-68. PubMed ID: 31764022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Updated Frequency of EGFR and KRAS Mutations in NonSmall-Cell Lung Cancer in Latin America: The Latin-American Consortium for the Investigation of Lung Cancer (CLICaP).
    Arrieta O; Cardona AF; Martín C; Más-López L; Corrales-Rodríguez L; Bramuglia G; Castillo-Fernandez O; Meyerson M; Amieva-Rivera E; Campos-Parra AD; Carranza H; Gómez de la Torre JC; Powazniak Y; Aldaco-Sarvide F; Vargas C; Trigo M; Magallanes-Maciel M; Otero J; Sánchez-Reyes R; Cuello M
    J Thorac Oncol; 2015 May; 10(5):838-843. PubMed ID: 25634006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retrospective study: platinum-based induction chemotherapy combined with gemcitabine or paclitaxel for stage IIB-IIIA central non-small-cell lung cancer.
    Lv C; Ma Y; Wu N; Yan S; Zheng Q; Sun Y; Li S; Fang J; Yang Y
    World J Surg Oncol; 2013 Mar; 11():76. PubMed ID: 23517534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Factor and Clinical Outcome in Stage III Non-Small Cell Lung Cancer: A Study Based on Real-World Clinical Data in the Korean Population.
    Kim HC; Ji W; Lee JC; Kim HR; Song SY; Choi CM; ;
    Cancer Res Treat; 2021 Oct; 53(4):1033-1041. PubMed ID: 33592139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The study of peri-operative chemotherapy in stage I-IIIa NSCLC].
    Liao ML; Zhou YZ; Ding JA; Ni GX; Zhao JM; Chen WH; Han BH; Shen J; Bai H; Chen ZW; Ji H; Wang HM; Zhou Z
    Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):962-6. PubMed ID: 12899797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Clinicopathologic and Molecular Tumor Features With Recurrence in Resected Early-Stage Epidermal Growth Factor Receptor-Positive Non-Small Cell Lung Cancer.
    Saw SPL; Zhou S; Chen J; Lai G; Ang MK; Chua K; Kanesvaran R; Ng QS; Jain A; Tan WL; Rajasekaran T; Lim DWT; Tan A; Fong KW; Takano A; Cheng XM; Lim KH; Koh T; Ong BH; Tan EH; Toh CK; Skanderup AJ; Tan SH; Tan DSW
    JAMA Netw Open; 2021 Nov; 4(11):e2131892. PubMed ID: 34739062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.